A 16,000% Problem: Why Workers’ Comp Can’t Get Drug Costs Under Control April 24, 2026 By Brian Allen Pharmacy costs in workers’ compensation continue to climb sharply, despite years of formulary adoption, generic mandates and managed care. The...
Purdue’s $5.5B Sentencing for Opioid Charges Delayed After Victims Show at Court April 22, 2026 By Dietrich Knauth A federal judge on Tuesday delayed the planned criminal sentencing of Purdue Pharma by one week, saying she wanted to...
Zantac Suits Tossed by Delaware Judge for Flawed Cancer Link April 17, 2026 A Delaware judge threw out lawsuits seeking to link the heartburn drug Zantac to cancer, freeing makers of the product...
Albertsons Reaches $774 Million Opioid Accord April 14, 2026 By Rainier Harris Albertsons Cos. announced a $774 million settlement to resolve all opioid-related claims, making the grocery chain one of the last...
Sedgwick: Australian Product Recalls Declined in Second Half of 2025 April 9, 2026 Pharmaceutical products and the food and drinks sectors saw big increases in product recalls in Australia in the second half...
Takeda, Lilly Rejected by Supreme Court on Actos Fraud Lawsuit March 23, 2026 By Greg Stohr The U.S. Supreme Court cleared the way for a multibillion-dollar racketeering lawsuit that accuses Takeda Pharmaceutical Co. and Eli Lilly...
Viatris Settles Lawsuit Over Use of Woman’s ‘Immortal’ Cells to Power Drug Research March 16, 2026 By Blake Brittain Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose tissue samples...
Moderna to Pay About $1 Billion to Settle Arbutus Litigation March 5, 2026 By Gerry Smith and Madison Muller Moderna Inc. agreed to pay $950 million to settle litigation related to the delivery technology behind its Covid shot, removing...
Moderna Will Pay up to $2.25 Billion to Settle COVID Vaccine Patent Dispute March 3, 2026 By Kamal Choudhury and Blake Brittain Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to...
BioNTech Sues Moderna for Patent Infringement Over COVID Shots February 20, 2026 By Blake Brittain German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna’s COVID-19 vaccine mNEXSPIKE infringes a...